Journal
JOURNAL OF IMMUNOLOGY
Volume 186, Issue 5, Pages 2897-2909Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1003187
Keywords
-
Categories
Funding
- Irish Health Research Board [PHD/2007/11]
- US Alpha One Foundation
- Medical Research Charities Group/Health Research Board
- Program for Research in Third Level Institutes
- Grants-in-Aid for Scientific Research [23256004, 22590360] Funding Source: KAKEN
Ask authors/readers for more resources
The T-cell Ig and mucin domain-containing molecules (TIMs) have emerged as promising therapeutic targets to correct abnormal immune function in several autoimmune and chronic inflammatory conditions. It has been reported that proinflammatory cytokine dysregulation and neutrophil-dominated inflammation are the main causes of morbidity in cystic fibrosis (CF). However, the role of TIM receptors in CF has not been investigated. In this study, we demonstrated that TIM-3 is constitutively overexpressed in the human CF airway, suggesting a link between CF transmembrane conductance regulator (CFTR) function and TIM-3 expression. Blockade of CFTR function with the CFTR inhibitor-172 induced an upregulation of TIM-3 and its ligand galectin-9 in normal bronchial epithelial cells. We also established that TIM-3 serves as a functional receptor in bronchial epithelial cells, and physiologically relevant concentrations of galectin-9 induced TIM-3 phosphorylation, resulting in increased IL-8 production. In addition, we have demonstrated that both TIM-3 and galectin-9 undergo rapid proteolytic degradation in the CF lung, primarily because of neutrophil elastase and proteinase-3 activity. Our results suggest a novel intrinsic defect that may contribute to the neutrophil-dominated immune response in the CF airways. The Journal of Immunology, 2011, 186: 2897-2909.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available